All stories tagged :

Pr Newswire

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy...

admin
Pr Newswire

Daré Bioscience Announces Reverse Stock Split

admin
Pr Newswire

Spectral AI Surpasses 90% of Pediatric Enrollment Target in Burn Centers...

admin
Pr Newswire

TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income...

admin
Pr Newswire

Cheche Group Announces Strategic Partnership with BAIC Group’s Insurance Provider

admin
Pr Newswire

Crown Laboratories, Inc. and BIOJUVE® Celebrate World Microbiome Day 2024

admin
Pr Newswire

MSME Day 2024: Alibaba.com Commits to Scaling AI Tools for MSMEs

admin
Pr Newswire

Recurrent Energy Closes $103 Million Tax Credit Transfer Agreement with Bank...

admin
Pr Newswire

Odaseva Raises $54M Series C Round to Expand Product Offerings and...

admin
Pr Newswire

Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological...

admin
Pr Newswire

EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or...

admin

Featured

Pr Newswire

Virbac : Declaration of the number of shares and voting rights...

admin
Pr Newswire

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s...

admin
Pr Newswire

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase...

admin
Pr Newswire

Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner

admin
admin

Virbac : Declaration of the number of shares and voting rights...

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal...